Does proton pump inhibitor reduce the antiaggregant efficacy of aspirin in ischemic stroke?
CONCLUSION: The combination of 30 mg lansoprazole and 100 mg aspirin does not cause a decrease in antiaggregant activity in the early period, but chronic use was not evaluated in this study. Patients with AR may benefit from an increase in the dose of aspirin.PMID:36474449
Source: Acta Neurologica Taiwanica - Category: Neurology Authors: Tu ğba Özel Ali Ünal Sebahat Özdem Babur Dora Source Type: research
More News: Aspirin | Brain | Ischemic Stroke | Lansoprazole | Neurology | Prevacid | Proton Pump Inhibitors PPIs | Statistics | Stroke | Study | Taiwan Health